Revitas to Present Best Practices for Managing Rebates and Supporting Compliance Initiatives at the Medicaid Drug Rebate Program Summit

Barry Hansen and Michael Panicaro will lead sessions on two pressing topics: rebate management and business regulations

Revitas to Present Best Practices for Managing Rebates and Supporting Compliance Initiatives at the Medicaid Drug Rebate Program Summit

Gregory FCAAlicia Buonanno, 610-228-2096

will lead two presentations at the upcoming 18th Annual , held September 9-11 in Chicago, and will exhibit at booth #23. The presentations, led by Barry Hansen, Product Manager for Revitas Government Pricing, and Michael Panicaro, Manager of Solution Engineering at Revitas, will each illustrate best practices for overcoming regulatory hurdles in the complex rebate system. The MDRP Summit is the authority on the Medicaid Drug Rebate Program and other public-sector reimbursement programs. Year after year, MDRP provides unparalleled access to the government regulators creating the rules, the industry leaders interpreting them, and the pharmaceutical executives implementing them.

Hansen and Panicaro will present “Take a Product through the Rebate System” on September 9 at 4:30 p.m. CDT. In an examination of each step of the MDRP process, Hansen and Panicaro will share a case study that will teach attendees how to move their product through the MDRP system, from initial claim to validation and disbursement, while avoiding margin erosion and maintaining compliance.

Hansen and Panicaro will also address the complicated process of identifying and implementing business rules within an organization on September 10 at 3:30 p.m. CDT in a presentation titled, “Translating Business Rules into System Processing.” In an age of increasingly complex government pricing mandates, business rules develop and evolve through multiple outlets, including federal and state governments, legal counsel, workflows, security, and system requirements. To successfully manage the influx of business regulations, organizations must understand the source of business rules, how to interpret these rules, and then how they can be expressed as requirements. Attendees will learn best practices for how to implement rules into their organizations even when the most beneficial implementation system is not obvious.

“The MDRP Summit draws government regulators, industry leaders, and pharmaceutical executives together to discuss new regulations and confer on the best ways to meet government expectations without sacrificing profitability,” said Hansen. “Revitas brings a unique perspective to the discussion based on our integrated approach to contracts, pricing, and compliance. Whether organizations are seeking to optimize their MDRP process or better implement business rules, solutions must extend beyond compliance to involve revenue management and ensure that business processes are not only auditable and reportable, but shore up margins and boost your bottom line.”

Find more information at the page or visit Revitas at booth #23 at the MDRP Summit.

Revitas, the leader in Enterprise Revenue Dynamics, delivers integrated solutions for contracts, pricing, and compliance that drive higher profitability and lower risk. Revitas empowers companies to optimize contract performance by defining, managing, and analyzing complex, multi-tier pricing incentives and enables positive proof of compliance with commercial, financial, and industry requirements. Powered by the secure, scalable, and standards-based Flex® platform, Revitas® applications speed time to market and improve visibility across B2B relationships. Hundreds of organizations across the most highly regulated and challenging industries leverage Revitas integrated solutions to save money, make money, and reduce risk. For details, visit or .

Suggested Articles

Nearly 10,000 patients involved in research studies were impacted by a third-party privacy breach that may have exposed their medical diagnoses.

Veterans Health Administration medical facilities currently have a paper medical record backlog that if stacked up would be 5.15 miles high, according to the…

The Department of Health and Human Services announced proposed changes to privacy restrictions on patients' substance use treatment records.